Back
  1. Home
  2. Profile of Mégane Jassin (ULiège)
Profil

Jassin Mégane

GIGA Immunobiology - Hematology

Département des sciences cliniques > GIGA

Département des sciences cliniques

See author's contact details
ORCID
0009-0001-3508-6065
Main Referenced Co-authors
Baron, Frédéric  (19)
Ehx, Grégory  (19)
E Silva, Bianca  (18)
Caers, Jo  (15)
Bocuzzi, Valentina  (11)
Main Referenced Keywords
CAR-T (10); Hematology (4); Myélome multiple (4); Immunology (3); Immunothérapie (3);
Main Referenced Disciplines
Hematology (23)
Immunology & infectious disease (8)
Oncology (6)
Biotechnology (1)
Microbiology (1)

Publications (total 28)

The most downloaded
165 downloads
Nguyen, T. T., Ho, P., Staudt, S., GREGOIRE, C., Ziegler-Martin, K., Jassin, M., Block, A., Hudecek, M., Melenhorst, J. J., Caers, J., & Luu, M. (October 2025). Fine tuning towards the next generation of engineered T cells. Nature Biomedical Engineering, 9 (10), 1610 - 1631. doi:10.1038/s41551-025-01492-8 https://hdl.handle.net/2268/337756

The most cited

10 citations (OpenAlex)

Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901 https://hdl.handle.net/2268/306375

E Silva, B.* , Daubry, A.* , Faville, C.* , De Voeght, A., Foguenne, J., Jassin, M., Kwan, O., Correia Da Cruz, L., Carriglio, G., Charles, S., Baron, F., Caers, J., Gothot, A., & Ehx, G. (2026). Biases introduced by Ficoll-based isolation in acute myeloid leukemia sample analyses support the use of hemolysis. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/341505.
* These authors have contributed equally to this work.

Jassin, M., Onkelinx, C., Bocuzzi, V., E Silva, B., Kwan, O., Block, A., Dubois, S., Daulne, C., Marcion, G., Ormenese, S., Di Valentin, E., Baron, F., GREGOIRE, C., Ehx, G., Nguyen, T. T., & Caers, J. (08 December 2025). Comparing a Novel Anti-BCMA NanoCAR with a Conventional ScFv-Based CAR for the Treatment of Multiple Myeloma. Cells, 14 (24), 1944. doi:10.3390/cells14241944
Peer Reviewed verified by ORBi

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Block, A., Marcion, G., Baron, F., Di Valentin, E., Ehx, G., Nguyen, T. T., & Caers, J. (18 November 2025). Design of a novel NanoCAR construct that compares well with a conventional ScFv-based CAR targeting BCMA on multiple myeloma [Poster presentation]. Bis annual meeting.

Nguyen, T. T., Ho, P., Staudt, S., GREGOIRE, C., Ziegler-Martin, K., Jassin, M., Block, A., Hudecek, M., Melenhorst, J. J., Caers, J., & Luu, M. (October 2025). Fine tuning towards the next generation of engineered T cells. Nature Biomedical Engineering, 9 (10), 1610 - 1631. doi:10.1038/s41551-025-01492-8
Editorial reviewed

Jassin, M., Block, A., Désiront, L., Vrancken, L., GREGOIRE, C., Baron, F., Ehx, G., Nguyen, T. T., & Caers, J.*. (11 July 2025). From spheroids to organoids: next-generation models for CAR-T cell therapy research in solid tumors. Frontiers in Immunology, 16. doi:10.3389/fimmu.2025.1626369
Peer Reviewed verified by ORBi

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (11 March 2025). Development of a Single-Domain Antibody-Based Radiopharmaceutical for Targeted Alpha Therapy of Multiple Myeloma [Poster presentation]. European Molecular Imaging Meeting (EMIM), Bilbao, Spain.
Editorial reviewed

Jassin, M., E Silva, B., Bocuzzi, V., Block, A., Marcion, G., Baron, F., Di Valentin, E., Ehx, G., Caers, J., Nguyen, T. T., & Onkelinx, C. (06 February 2025). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. 7th European CAR T-cell Meeting, Strasbourg, France.

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (29 January 2025). CD38-based Targeted Alpha Therapy for the treatment of multiple myeloma [Poster presentation]. Seminaire Télévie, 4000 - Liège, Belgium.
Editorial reviewed

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (29 January 2025). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2025, Liège, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Charles, S., Dubois, S., Baron, F., & Ehx, G. (2025). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. EACR Conference Persister Cells: from Bacteria to Cancer.

Jassin, M. (05 December 2024). Présentation sur la recherche en cancérologie et le Télévie [Paper presentation]. Cours de Sciences biologiques à l'AR Montegné, Liège, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance. European Journal of Immunology. doi:10.1002/eji.202470200
Peer Reviewed verified by ORBi

Jassin, M., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., Nguyen, T. T., & Onkelinx, C. (31 May 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Recent insights into Immuno-Oncology, Anvers, Belgium.

Jassin, M., Onkelinx, C., E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (23 May 2024). Production and development of a new immunotherapeutic targeting multiple myeloma [Paper presentation]. EDT - Immunology Day 2024, Liège, Belgium.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Paper presentation]. EDT-Immunology PhD Day.

Jassin, M., Bocuzzi, V., Nguyen, T. T., Onkelinx, C., E Silva, B., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., & Caers, J. (22 April 2024). Production and development of a new immunotherapeutic targeting multiple myeloma [Paper presentation]. YBis Research Seminars: Immunology-Oncology, Liège, Belgium.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (15 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. EBMT - EHA 6th European CAR T-cell Meeting, Valence, Spain.

Jassin, M., Chloé Onkelinx, E Silva, B., Bocuzzi, V., Marcion, G., Ehx, G., Baron, F., Di Valentin, E., Caers, J., & Nguyen, T. T. (06 February 2024). CAR-T and nanoCAR-T for multiple myeloma: Does smaller mean smarter ? [Poster presentation]. Séminaire Télévie 2024.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Poster presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Faville, C.* , E Silva, B.* , Jassin, M., DUBOIS, S., Daulne, C., Cobraiville, G., De Voeght, A., Baron, F., Fillet, M.* , & Ehx, G.*. (06 February 2024). Discovery And Targeting of Persister-specific Antigens in Acute Myeloid Leukemia [Paper presentation]. Télévie Seminar.
* These authors have contributed equally to this work.

Onkelinx, C., & Jassin, M. (05 February 2024). Caractérisation et comparaison entre un CAR-T standard et d'un nanoCAR-T ciblant BCMA dans le myélome multiple [Poster presentation]. Mémoire HEPL.

Jassin, M. (2024). Présentation sur la recherche en cancérologie et le Télévie [Paper presentation]. Cours de Sciences biologiques à l'AR Montegné.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. yBIS First Annual Meeting.

E Silva, B., Daubry, A., Faville, C., Jassin, M., Baron, F., & Ehx, G. (2024). IFN-γ predisposes acute myeloid leukemia to therapy resistance [Poster presentation]. GIGA Day 2024.

E Silva, B., Faville, C., Jassin, M., DUBOIS, S., De Voeght, A., Baron, F., & Ehx, G. (09 September 2023). Characterizing the immune recognition of chemo-persister blasts in acute myeloid leukemia [Poster presentation]. GIGA Day 2023.

Jassin, M. (09 February 2023). Evaluation of new immunotherapeutic targets for multiple myeloma [Poster presentation]. 5th European CAR T-cell Meeting, Rotterdam, Netherlands.

Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901
Peer Reviewed verified by ORBi

Lebrun, M., Lambert, J., Zhou, M., Jassin, M., Oliver, S., Arvin, A., & Sadzot, C. (August 2021). The role of ORF9p in VZV-induced cell-cell fusion [Paper presentation]. 45th annual International Herpesvirus Workshop.

Contact ORBi